人参归脾丸对缺铁性贫血患者HB、RBC、HCT的影响

Effect of RenShen GuiPiWan on HGB,RBC and HCT of Patients with Iron-deficiency Anemia

目的:观察人参归脾丸对缺铁性贫血(IDA)患者血红蛋白(HB)、红细胞(RBC)、血细胞比容(HCT)的影响。方法:将80例IDA患者随机分为观察组和对照组各40例。2组均服用琥珀酸亚铁片,0.1 g/次,3次/d,同时每次给予等量维生素C同服以利吸收;观察组同时给予人参归脾丸,9 g/次,3次/d。2组均以治疗1个月为1个疗程,治疗1个疗程后评价疗效。结果:治愈率观察组为80.00%,对照组为50.00%,2组相比差异显著(P<0.05)。总有效率观察组为95.00%,对照组为75.00%,2组相比差异显著(P<0.05)。HB、RBC、HCT治疗后2组均明显增高(P<0.05),治疗后组间比较差异显著(P<0.05)。结论:人参归脾丸可改善IDA患者HB、RBC、HCT指标。

Objective： To verify the effects ofRenShen GuiPiWan on hemoglobin （HB）, red blood cell （RBC） and hematocrit （HCT） of patients suffering from iron-deficiency anemia. Method： Eighty patients were randomly separated into the observation group and the control group. Both groups took ferrous succinate tablets, 0.1 g once, three times each day, and the same amounts of vitamin C to promote absorption; the observation group received RertShen GuiPiWan, 9 g once, three times each day. One course of treatment was one month, clinical effects were observed after treating for one course of treatment. Result： Cure rate of the observation group was 80.00%, higher than 50.00% of the control group with significant difference （P〈0.05）. Total effective rates of the observation group and the control group were 95.00% and 75.00%, comparison between both groups demonstrated significant difference （P〈0.05）. HB, RBC and HCT were improved of both groups after treating （P〈0.05）, comparison between both groups showed significant difference （P〈0.05）. Conclusion： RenShen GuiPiWan could improve the indexes including HB, RBC and HCT.